» Articles » PMID: 30078050

Hepatocyte-specific Contrast Media: Not So Simple

Overview
Journal Pediatr Radiol
Specialty Pediatrics
Date 2018 Aug 6
PMID 30078050
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocyte-specific contrast media are gadolinium chelates that are taken up by hepatocytes and partially cleared via the biliary tree. The absence of lesional uptake of the contrast media in the hepatobiliary phase is a marker of either the absence of hepatocytes or of poorly functioning, neoplastic hepatocytes. Uptake of the contrast media in the hepatobiliary phase, whether equal to or greater than background liver, reflects the presence of hepatocytes but does not equate to absence of neoplasia. Accurate diagnosis of liver lesions utilizing hepatocyte-specific contrast media requires an understanding of the mechanisms of uptake and clearance of the contrast media to avoid misdiagnosis. In this review we discuss the mechanisms of hepatocellular transport of hepatocyte-specific contrast media and utilize an understanding of those mechanisms to discuss the imaging appearance of a subset of hepatocellular lesions that can be seen in the pediatric and young adult liver. We pay particular attention to lesions that appear iso- to hyperintense in the hepatobiliary phase but have the potential for adverse clinical outcomes. We also discuss strategies for identifying these lesions.

Citing Articles

Contrast enhanced ultrasound of liver lesions in patients treated for childhood malignancies.

Mostafa A, Abramson Z, Ghbrial M, Biswas S, Chan S, Darji H Cancer Imaging. 2024; 24(1):115.

PMID: 39210481 PMC: 11360734. DOI: 10.1186/s40644-024-00750-3.


Fontan-associated liver disease: Diagnosis, surveillance, and management.

de Lange C, Moller T, Hebelka H Front Pediatr. 2023; 11:1100514.

PMID: 36937979 PMC: 10020358. DOI: 10.3389/fped.2023.1100514.


Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.

Aslam A, Kamath A, Spieler B, Maschiocchi M, Sabottke C, Chernyak V Abdom Radiol (NY). 2021; 46(8):3565-3578.

PMID: 33856509 DOI: 10.1007/s00261-021-03076-x.


Robotic resection of liver focal nodal hyperplasia guided by indocyanine green fluorescence imaging: A preliminary analysis of 23 cases.

Li C, Zhou Z, Tan X, Wang Z, Liu Q, Zhao Z World J Gastrointest Oncol. 2020; 12(12):1407-1415.

PMID: 33362911 PMC: 7739148. DOI: 10.4251/wjgo.v12.i12.1407.


Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.

DiPaola F, Trout A, Walther A, Gupta A, Sheridan R, Campbell K Dig Dis Sci. 2019; 65(4):1239-1251.

PMID: 31549332 PMC: 8180198. DOI: 10.1007/s10620-019-05834-w.


References
1.
Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, Koda W . Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. Radiology. 2010; 256(3):817-26. DOI: 10.1148/radiol.10092214. View

2.
Bioulac-Sage P, Sempoux C, Balabaud C . Hepatocellular adenoma: Classification, variants and clinical relevance. Semin Diagn Pathol. 2017; 34(2):112-125. DOI: 10.1053/j.semdp.2016.12.007. View

3.
Katabathina V, Menias C, Shanbhogue A, Jagirdar J, Paspulati R, Prasad S . Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011; 31(6):1529-43. DOI: 10.1148/rg.316115527. View

4.
Hope T, Fowler K, Sirlin C, Costa E, Yee J, Yeh B . Hepatobiliary agents and their role in LI-RADS. Abdom Imaging. 2014; 40(3):613-25. DOI: 10.1007/s00261-014-0227-5. View

5.
Quaglia A, Tibballs J, Grasso A, Prasad N, Nozza P, Davies S . Focal nodular hyperplasia-like areas in cirrhosis. Histopathology. 2002; 42(1):14-21. DOI: 10.1046/j.1365-2559.2003.01550.x. View